ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Modulation of Presynaptic Inhibitory Retinal Circuits for Retinal Ganglion Cell Neuroprotection in Glaucoma.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Glaucoma is a leading cause of irreversible blindness, yet the circuit-level mechanisms contributing to retinal ganglion cell (RGC) degeneration remain incompletely defined. Although multiple neuroprotective strategies have been explored, clinical translation remains limited. Here, we identify early dysfunction of inner retinal inhibitory circuitry as a modifiable contributor to RGC vulnerability during ocular hypertensive stress. In mouse ocular hypertension models, inner nuclear layer neurons exhibited increased c-fos expression and enhanced oscillatory potential-associated differential electroretinography signals before substantial RGC loss was detected, suggesting early retinal circuit hyperactivity. Broad pharmacological attenuation of GABAergic and glycinergic inhibitory signaling improved RGC survival without reducing intraocular pressure, supporting a functional contribution of inhibitory neurotransmission to RGC vulnerability. Moreover, Cre-dependent AAV delivery of Lin28, an RNA-binding regulator of post-transcriptional gene expression, to Vgat-positive inhibitory interneurons increased RGC survival compared with Vgat-EGFP controls and Vglut2-lineage Lin28 expression. Vgat-targeted Lin28 also reduced c-fos expression and oscillatory potential-associated differential electroretinogram abnormalities, indicating suppression of ocular hypertension-associated inner retinal hyperactivity. In addition, ocular hypertension was associated with altered sleep architecture, and Vgat-targeted Lin28 expression was associated with mitigation of these alterations. These findings position presynaptic inhibitory retinal circuitry as an early and modifiable contributor to glaucomatous RGC vulnerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.